Dermapharm Holding SE (ETR:DMP) shareholders are probably feeling a little disappointed, since its shares fell 2.9% to €34.70 in the week after its latest quarterly results. It was a workmanlike ...
Today, we'll introduce the concept of the P/E ratio for those who are learning about investing. To keep it practical, we'll show how Dermapharm Holding SE's (ETR:DMP) P/E ratio could help you assess ...
DGAP-News: Dermapharm Holding SE / Key word(s): 9 Month figures Dermapharm Holding SE: strong EBITDA growth in Q3 2021 16.11.2021 / 07:30 The issuer is solely responsible for the content of this ...
Grünwald, 22 March 2022 - Dermapharm Holding SE ("Dermapharm"), a fast-growing manufacturer of branded pharmaceuticals, today publishes its unaudited preliminary IFRS consolidated financial figures ...
Grünwald, 7 July 2021 - Dermapharm Holding SE ("Dermapharm"), a rapidly growing manufacturer of branded pharmaceuticals, is expanding its group of companies via Dermapharm AG to include an investment ...
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). To keep the ...
BERLIN (Reuters) - Dermapharm aims to start making the COVID-19 vaccine from BioNTech and U.S. partner Pfizer at a second site in Germany in May, its chief executive said, as part of efforts to ramp ...
Impressive organic growth in existing branded pharmaceuticals business at German and international companies compensates for drop in revenue due to scheduled end of pandemic-related boom in vaccine ...
FRANKFURT (Reuters) - Privately-held German generic drugmaker Dermapharm has attracted interest from buyout groups in a potential 1 billion euro (£730.3 million) deal after being put up for sale by ...
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Passive investing in index funds can generate returns that roughly match the overall market.
BERLIN, Feb 9 (Reuters) - Dermapharm DMPG.DE aims to start making the COVID-19 vaccine from BioNTech 22UAy.DE and U.S. partner Pfizer PFE.N at a second site in Germany in May, its chief executive said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results